Cargando…

Characterization of Different Subtypes of Immune Cell Infiltration in Glioblastoma to Aid Immunotherapy

Glioblastoma multiforme (GBM) has been identified as a frequently occurring adult primary brain cancer that is highly aggressive. Currently, the prognostic outcome for GBM patients is dismal, even with intensive treatment, and the median overall survival (OS) is 14.6 months. Immunotherapy, which is...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Peng, Li, Zhenqing, Li, Yuchen, Zhang, Yuelin, Miao, Xingyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254719/
https://www.ncbi.nlm.nih.gov/pubmed/35799789
http://dx.doi.org/10.3389/fimmu.2022.799509